About Pleroo Research
Embedded Files
Pleroo is Greek for "fullness', "to fulfill" or "to complete".
For Pleroo Research, it signifies the nature of our mission; to contribute to science and humanity by a deliberate intention to serve, excel in knowledge and skill with strong virtues of a sound mind and purpose.
Our Mission
To nurture, apply and promote deep scientific expertise and analytical approach to research, enabling our partners and clients a faster accomplishment of business objectives.
We understand business objectives and work alongside bringing in new perspectives, early evaluations and designs enabling strategic decision making. We would thus play our part in promoting innovation, new ventures and independent thinking.
We Value
Your objectives and anticipated outcomes
Innovative and methodical approach to challenges
Integrity and safety of data
Your time
Your rightful need to be informed at every step
The People Behind Pleroo
Biju Benjamin Ph.D
Dr. Biju Benjamin is a Scientist-Entrepreneur with a passion for novel technologies and a mission for well-being. A strong advocate of cross functional applications like mathematical approaches in biology for discovery and clinical development of new drugs or life changing solutions. He is also technology enthusiast. Dr. Benjamin has his core expertise in DMPK, Clinical Pharmacology and mathematical modelling with a sound background of Pharmaceutical Sciences and Pharmacology. He brings along a balanced blend of experimental, data analysis and mathematical modelling applied to Drug discovery and Clinical Development during his career, covering therapeutic areas of cancer, diabetes, anti-infectives, inflammation, allergy, immunology, and CNS disorders. A rich wet lab research experience spanning over a decade complemented by translational research and mathematical modelling experience applied to clinical development providing an end-to-end visibility of drug discovery and clinical development process. Dr. Benjamin led the ADME and PK-PD functions being part of ‘early development engine’ Vanthys, a joint venture between Eli-Lilly and Jubilant (Vanthys), and various functional roles in drug discovery with leading Indian research companies Ranbaxy and Dr. Reddys. In his consulting role he has held senior positions and advisory roles in various organisations Biju Benjamin is a Ph.D from BITS, Pilani and has a Masters degree in Pharmacology from MAHE, Manipal. He is also the primary author or contributor to 16 publications or poster presentations, spanning areas of bioanalysis, pharmacology and pharmacokinetics.
Harsha Doddihal M.D
Dr Harsha Doddihal is a healthcare, life science and pharmaceutical professional with entrepreneurial DNA. He is a highly accomplished leader with extensive experience and a proven track record of success in the pharmaceutical industry, specialising in oncology and immunology. Harsha brings a wide experience in overseeing clinical development processes, achieving cost efficiencies in clinical trials, and ensuring regulatory compliance. He has been leadership positions directing cross-functional teams to consistently accomplish organisational objectives and is an expert in regulatory submissions and stakeholder engagement, ensuring compliance with global regulatory standards.
Dr Harsha is a Board Certified Radiation Oncologist and is an Executive MBA candidate from IMD, Lausanne. He has certifications in Operations Management, Finance and Entrepreneurship from US universities.
Harsha Co-founded a company in digital health and home health care. The company works to enhance healthcare accessibility for the elderly population, utilizing technology effectively to simplify health navigation and encourage wellness. Harsha has demonstrating strong leadership in growth strategies, digital health initiatives, talent acquisition, and meticulous patient services monitoring.
In his past roles he has played a key role in making marketing decisions, building partnerships, and developing innovative healthcare services.
Harsha is the Lead clinical consultant with focus on Oncology area as well as development of NCE, Bispecifics, Trispecifics or speciality products in clinical domain.
Ramdas Manakkote M.Pharm
Mr Ramdas Manakkote is a Formulation Development scientist with expertise in Preformulation, Formulation development,process development, scaleup of formulations from bench scale(few grams) to commercial manufacturing scale, trouble shooting of manufacturing process.He also reviews the analytical method development for Assay RS and Dissolution, Biorelevent dissolution method development, Discriminatory dissolution media selection. He has developed both human and veterinary formulations for India,US(ANDA) and Europe market. He has expertise on immediate release,prolonged release, delayed release formulation including pellets,bilayer tablets,PFOS etc. Has worked on stability critical molecules, stabilisation approaches and selection of suitable packing material for dosage forms. Has experience in quick formulation development with minimum trials based on DOE and scientificatlly justified components of formulation.Has hands on experience in preclinical formulation development on various animals. Has experience in evaluating formulation suitability for achieving bioequivalence. Review of formulation approaches and changes in formulation required for achieving a positive pilot/pivotal bioequivalence studies. Ramdas Manakkote has worked in various functional roles in leading Indian research companies Dr. Reddys,Cadilla , ranbaxy and Aizant.Ramdas Manakkote has a Masters degree in Pharmaceutics from Kerala university. He has patents and publications in formulation development.Pleroo Research operates from Bangalore, India.
Pleroo Research operates from Bangalore, India.
Report abuse